head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing
ISSN: 1312-773X (Online)
Issue: 2017, vol. 23, issue 4
Subject Area: Medicine
DOI: 10.5272/jimab.2017234.1800
Published online: 08 December 2017

Original article

J of IMAB 2017 Oct-Dec;23(4):1800-1803
Tsvetomir Dimitrov1ORCID logo Corresponding Autoremail, Tsvetelina Mihaylova1ORCID logo, Desislava Todorova2ORCID logo,
1) Clinical Department of Ophthalmology, First General Hospital for Active Treatment Sofia AD, Sofia City, Bulgaria
2) Department of Medical Pedagogy, Faculty of Public Health, Medical University, Sofia City, Bulgaria
3) Department of Preventive Medicine, Faculty of Public Health, Medical University, Sofia City, Bulgaria.

Glaucoma is characterized by increased intraocular pressure (IOP), which results in impairment of the optic nerve and vision both in children and adults. The aim of the study is an analysis of the distinguishing characteristics of diagnostics and therapy of glaucoma in children and adults. A documentary method of investigation of scientific sources - based on clinical practice - is applied. The methodology of study comprises investigation of the diagnostics of glaucoma and of the methods for its treatment. It was found that the specification of diagnosis of glaucoma is possible after confirmation of the results from the application of different methods and examinations, which were described. The methods of the present day for medicinal and surgical treatment were systematized. The monitoring of the condition of eyes and vision for early detection of abnormalities is an important part of the cares for the general health in every human age.

Keywords: glaucoma, diagnostics, therapy, distinguishing characteristics,

pdf - Download FULL TEXT /PDF 479 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Dimitrov T, Mihaylova T, Todorova D. Distinguishing characteristics in the diagnostics and therapy of glaucoma in children and adults. J of IMAB. 2017 Oct-Dec;23(4):1800-1803. DOI: 10.5272/jimab.2017234.1800

Corresponding AutorCorrespondence to: Tsvetomir Dimitrov, Clinical Department of Ophthalmology, First General Hospital for Active Treatment Sofia AD; 37, Patriarch Evtimiy Blvd., Sofia 1000, Bulgaria; E-mail: tsdimitrov.or@gmail.com

1. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007 Nov;114(11):1965-72. [PubMed] [CrossRef]
2. Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, et al. Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol. 2010 Mar;128(3):276-87. [PubMed] [CrossRef]
3. National Institute for Health and Clinical Excellence. CG85: Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension. April 2009.
4. NHS Information Centre for Health and Social Care. Prescription cost analysis 2007.
5. Owen CG, Carey IM, De Wilde S, Whincup PH, Wormald R, Cook DG. The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003. Br J Ophthalmol. 2006 Jul;90(7):861-8. [PubMed] [CrossRef]
6. Houde M, Castilloux AM, Tingey D, Assalian A, LeLorier J. Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers. Can J Ophthalmol. 2003;38(6): 469-75. [PubMed]
7. Vinker S, Kaiserman I, Waitman DA, Blackman S, Kitai E. Prescription of ocular beta-blockers in patients with obstructive pulmonary disease: Does a central electronic medical record make a difference? Clin Drug Investig. 2006; 26(9):495-500. [PubMed]
8. Schmier JK, Covert DW, Lau EC. Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma. Clin Drug Investig. 2012 Dec;32(12):835–42. [PubMed] [CrossRef]
9. Maier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ. 2005 Jul;331(7509):134. [PubMed] [CrossRef]
10. Wentz SM, Kim NJ, Wang J, Amireskandari A, Siesky B, Harris A. Novel therapies for open-angle glaucoma. F1000Prime Rep. 2014 Nov;6:102. [PubMed] [CrossRef]
11. Reardon G, Kotak S, Schwartz GF. Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence. 2011; 5:441-63. [PubMed] [CrossRef]
12. Rocha-Sousa A, Rodrigues-Araujo J, Gouveia P, Barbosa-Breda J, Azevedo-Pinto S, Pereira-Silva P, et al. New therapeutic targets for intraocular pressure lowering. ISRN Ophthalmol. 2013;2013:261386. [CrossRef]
13. Aptel F, Chiquet C, Romanet JP: Intraocular pressure-lowering combination therapies with prostaglandin analogues. Drugs. 2012 Jul;72(10):1355-71. [PubMed] [CrossRef]
14. Hommer A. Role of fixed combinations in the management of open-angle glaucoma. Expert Rev Pharmacoecon Outcomes Res. 2011 Feb;11(1):91-9. [PubMed] [CrossRef]
15. Hollo G, Topouzis F, Fechtner RD. Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice. Expert Opin Pharmacother. 2014 Aug;15(12):1737-47. [PubMed] [CrossRef]
16. Stalmans I, Sunaric Megevand G, Cordeiro MF, Hommer A, Rossetti L, Goni F, et al. Preservative-free treatment in glaucoma: who, when, and why. Eur J Ophthalmol. 2013 Jul-Aug;23(4):518-25. [PubMed] [CrossRef]
17. Bagnis A, Papadia M, Scotto R, Traverso CE. Antiglaucoma drugs: the role of preservative-free formulations. Saudi J Ophthalmol. 2011 Oct-Dec;25(4):389-394. [CrossRef]
18. Kopczynski C, Epstein D: Emerging trabecular outflow drugs. J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):85-87. [PubMed] [CrossRef]
19. Carta F, Supuran CT, Scozzafava A. Novel therapies for glaucoma: a patent review 2007-2011. Expert Opin Ther Pat. 2012 Jan;22(1):79-88. [PubMed] [CrossRef]
20. Janz NK, Wren PA, Lichter PR, Musch DC, Gillespie BW, Guire KE, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001 Nov;108(11):1954-65. [PubMed] [CrossRef]..

Received: 09 September 2017
Published online: 08 December 2017

back to Online Journal